Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

A Genetic Variant in Primary miR-378 Is Associated with Risk and Prognosis of Hepatocellular Carcinoma in a Chinese Population

  • Jiaze An,

    Affiliation Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, China

    ⨯
  • Jibin Liu,

    Affiliation Department of Hepatobiliary Surgery, Nantong Tumor Hospital, Nantong, Nantong, Jiangsu, China

    ⨯
  • Li Liu,

    Affiliation Digestive Endoscopy Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

    ⨯
  • Yao Liu,

    Affiliation Pathology Center and Department of Pathology, Soochow University, Suzhou, Jiangsu, China

    ⨯
  • Yun Pan,

    Affiliation Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China

    ⨯
  • Mingde Huang,

    Affiliation Department of Oncology, Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, Jiangsu, China

    ⨯
  • Fuzhen Qi,

    Affiliation Department of Hepatopancreatobiliary Surgery, Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, Jiangsu, China

    ⨯
  • Juan Wen,

    Affiliation Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China

    ⨯
  • Kaipeng Xie,

    Affiliation Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China

    ⨯
  • Hongxia Ma,

    Affiliations Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Jiangsu, China

    ⨯
  • Hongbing Shen,

    Affiliations Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Jiangsu, China

    ⨯
  • Zhibin Hu

    zhibin_hu@njmu.edu.cn

    Affiliations Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Jiangsu, China

    ⨯

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.